Table 2.
Final diagnosis | Reviewer 1 | Reviewer 2 | ||||||
---|---|---|---|---|---|---|---|---|
n = 74 | SLC (n = 58) | BCT (n = 16) | P | n = 74 | SLC (n = 58) | BCT (n = 16) | P | |
Size, cm | 11.3 (2–30) | 10.7 (2–30) | 9.8 (3.6–22) | 0.641 | 11.8 (2–30) | 10.9 (2–30) | 9.9 (3.6–22) | 0.441 |
Side | ||||||||
Right | 38 (51.4%) | 32 (55.2%) | 6 (37.5%) | 0.357 | 38 (51.4%) | 32 (55.2%) | 6 (37.5%) | 0.357 |
Left | 26 (35.1%) | 18 (31%) | 8 (50%) | 26 (35.1%) | 18 (31%) | 8 (50%) | ||
Central | 10 (13.5%) | 8 (13.8%) | 2 (12.5%) | 10 (13.5%) | 8 (13.8%) | 2 (12.5%) | ||
Solitary | 31 (41.9%) | 20 (34.5%) | 11 (68.8%) | 0.021 | 31 (41.9%) | 20 (34.5%) | 11 (68.8%) | 0.021 |
Suspicious wall | 48 (64.9%) | 33 (56.9%) | 15 (93.8%) | 0.007 | 60 (81.1%) | 45 (77.6%) | 15 (93.8%) | 0.277 |
Septation | 61 (82.4%) | 45 (77.6%) | 16 (100%) | 0.058 | 59 (79.7%) | 43 (74.1%) | 16 (100%) | 0.031 |
Suspicious septation | 29 (39.2%) | 21 (36.2%) | 8 (50%) | 0.317 | 40 (54.1%) | 28 (14.3%) | 12 (75%) | 0.088 |
Suspicious intracystic component | 26 (35.1%) | 16 (27.6%) | 10 (62.5%) | 0.01 | 39 (52.7%) | 26 (44.8%) | 13 (81.3%) | 0.012 |
IHBD | 27 (36.5%) | 17 (29.3%) | 10 (62.5%) | 0.015 | 22 (29.7%) | 13 (22.4%) | 9 (56.3%) | 0.009 |
Suspicious LN | 1 (1.4%) | – | 1 (6.3%) | 0.216 | 1 (1.4%) | – | 1 (6.3%) | 0.216 |
Radiology diagnosis | SLC (n = 25) | SLC (n = 2) | SLC (n = 31) | – | ||||
BCT (n = 33) | BCT (n = 14) | BCT (n = 27) | BCT (n = 16) |
Bold variables are those which were significantly associated with BCT.
BCT, biliary cystic tumour; IHBD, intrahepatic biliary dilatation; LN, lymph nodes; SLC, simple liver cyst.